Your browser doesn't support javascript.
loading
Progress and prospects in treating postmenopausal vaginal atrophy.
Winneker, R C; Harris, H A.
Affiliation
  • Winneker RC; rwinneker@aol.com
Clin Pharmacol Ther ; 89(1): 129-32, 2011 Jan.
Article in En | MEDLINE | ID: mdl-20944561
Anatomically described as a "potential space," the vagina is a highly estrogen-responsive organ, and its biology changes dramatically at menopause. After menopause, many women experience vaginal dryness and/or dyspareunia, which are caused primarily by regression of the vaginal epithelium.Unlike vasomotor symptoms, which typically resolve overtime, vaginal atrophy remains a persistent consequence of the menopausal transition. This article discusses current trends and potential future treatments that may improve choices for menopausal and postmenopausal women.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vagina / Postmenopause Limits: Aged / Aged80 / Animals / Female / Humans / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2011 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vagina / Postmenopause Limits: Aged / Aged80 / Animals / Female / Humans / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2011 Document type: Article Country of publication: United States